Position in PFE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,598,084,183
+$206,846,437 QoQ
Shares Held
56,911,830
+1.9% QoQ
Ownership
0.999%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 65.90060625356801.ToString("F0")%
Shared 25.98790796219345.ToString("F0")%
None 8.111485784238532.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $7,300,763,534 across 12 Drug Manufacturers - General names. PFE ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,434,302 | $3,283,880,778 | |
| 2 | PFE |
Pfizer Inc
This page
|
56,911,830 | $1,598,084,183 | |
| 3 | ABBV |
AbbVie Inc.
|
5,610,330 | $1,220,190,668 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,281,609 | $875,467,841 | |
| 5 | BIIB |
Biogen Inc.
|
720,629 | $132,112,911 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,050,815 | $63,731,927 | |
| 7 | NVS |
Novartis AG
|
246,655 | $37,676,550 | |
| 8 | MRK |
Merck & Co., Inc.
|
271,829 | $32,698,308 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,598,084,183 | 56,911,830 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,391,237,746 | 55,873,002 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,467,359,053 | 57,588,660 | Shares | Defined | 2025-10-29 | |
| 2025-06-30 | $1,829,497,563 | 75,474,322 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,911,810,709 | 75,446,358 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,029,604,370 | 76,502,238 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,059,134,737 | 71,151,857 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,008,797,682 | 71,794,056 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,930,080,400 | 69,552,447 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,972,300,432 | 68,506,441 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,997,083,467 | 60,207,521 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,018,209,450 | 55,022,068 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,204,716,123 | 54,037,160 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,525,228,379 | 49,282,365 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,809,214,224 | 41,344,018 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,215,565,966 | 42,257,600 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,246,358,227 | 43,391,119 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,999,049,053 | 33,853,498 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,460,741,658 | 33,962,838 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,343,346,046 | 34,304,036 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,278,923,019 | 35,300,111 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,313,976,419 | 35,696,181 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $1,329,522,585 | 38,183,057 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,228,322,319 | 39,591,755 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $1,213,931,576 | 39,199,927 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||